Modification of the caffeine-induced locomotor stimulation by a cholinergic mechanism.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology*; D001590:Benztropine / Q000494:pharmacology*; D002110:Caffeine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004357:Drug Synergism; D005260:Female; D008124:Locomotion / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains; D010830:Physostigmine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013997:Time Factors
D000978:Antiparkinson Agents; D010879:Piperazines; D011743:Pyrimidines; D001590:Benztropine; D002110:Caffeine; D001285:Atropine; D012110:Reserpine; D010830:Physostigmine; D003000:Clonidine